Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial

Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial

Objective: Major depressive disorder (MDD) is predicted to be the first cause of burden of disease. The antidepressant activity of gemfibrozil has been recently considered. This study was designed to evaluate the effectiveness of gemfibrozil as a sertraline adjunct in treating patients with MDD....

Full description

Bibliographic Details
Main Authors: Atefeh Zandifar, Rahim Badrfam, Ahmad Shamabadi, Shakiba Jalilevand, Shayan Pourmirbabaei, Farbod Torkamand, Erfan Sahebolzamani, Shahin Akhondzadeh
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2021-01-01
Series:Iranian Journal of Psychiatry
Subjects:
Adjunctive Treatment
Depression
Gemfibrozil
Major Depressive Disorder
Randomized Controlled Trial
Online Access:https://ijps.tums.ac.ir/index.php/ijps/article/view/2338

Internet

https://ijps.tums.ac.ir/index.php/ijps/article/view/2338

Similar Items